Atlas Trials

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001

Clinical trial NCT04290676 · COMPLETED

Trial details

NCT number
NCT04290676
Sponsor
EyePoint Pharmaceuticals, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Cataract
Start date
2019-11-13
Primary completion
2020-05-01
Enrollment
527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.